Page 54 - 2023-08-中国全科医学
P. 54
2023年3月 第26卷 第8期 http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn ·951·
·论著·
HITH-4 远红外线治疗仪联合多磺酸粘多糖乳膏对糖尿病
血液透析患者动静脉内瘘功能的保护效果研究
扫描二维码
胡春燕,李雅婧,耿同会,张东雪 * 查看原文
【摘要】 背景 动静脉内瘘的功能维护对糖尿病血液透析患者至关重要。远红外线照射可以明显改善糖尿病血
液透析患者动静脉内瘘功能的不良状况,但 HITH-4 远红外线治疗仪联合多磺酸粘多糖乳膏对糖尿病血液透析患者动
静脉内瘘功能的保护作用的有效性评价报道较少。目的 探讨 HITH-4 远红外线治疗仪联合多磺酸粘多糖乳膏对糖尿
病血液透析患者动静脉内瘘功能的保护效果。方法 选取 2020-01-01 至 2020-06-01 在河北医科大学第四医院肾内科
应用自体动静脉内瘘的糖尿病血液透析患者 60 例。将患者随机分为两组,每组 30 例,对照组:应用多磺酸粘多糖乳
膏局部涂抹;干预组:应用 HITH-4 远红外线治疗仪进行内瘘侧肢体照射并局部涂抹多磺酸粘多糖乳膏。干预半年,
比较两组患者针眼愈合时间、血痂消失时间、透析血流量、透析动脉压、肱动脉血流量以及内瘘并发症发生情况。结
果 两组患者一般情况比较,差异无统计学意义(P>0.05)。干预组针眼愈合时间与血痂消失时间短于对照组,治疗
后透析血流量和动脉压高于对照组,肱动脉血流量多于对照组(P<0.05)。干预组患者内瘘并发症发生率低于对照组
(P<0.05)。结论 HITH-4 远红外线治疗仪联合多磺酸粘多糖乳膏维护动静脉内瘘,能够降低血管狭窄的风险及血
管并发症的发病风险,有效地维护了糖尿病血液透析患者动静脉内瘘的功能。
【关键词】 HITH-4 远红外线;多磺酸粘多糖乳膏;喜辽妥;糖尿病;肾透析;动静脉内瘘;肱动脉血流量
【中图分类号】 R 587.24 【文献标识码】 A DOI:10.12114/j.issn.1007-9572.2022.0550
胡春燕,李雅婧,耿同会,等 . HITH-4 远红外线治疗仪联合多磺酸粘多糖乳膏对糖尿病血液透析患者动静脉内
瘘功能的保护效果研究[J]. 中国全科医学,2023,26(8):951-954. [www.chinagp.net]
HU C Y,LI Y J,GENG T H,et al. Protective effect of far infrared therapy using HITH-4 type apparatus and external use
of hirudoid for autogenous arteriovenous fistula in diabetic dialysis patients[J]. Chinese General Practice,2023,26(8):
951-954.
Protective Effect of Far Infrared Therapy Using HITH-4 Type Apparatus and External Use of Hirudoid for Autogenous
*
Arteriovenous Fistula in Diabetic Dialysis Patients HU Chunyan,LI Yajing,GENG Tonghui,ZHANG Dongxue
Department of Nephrology,the Forth Hospital of Hebei Medical University,Shijiazhuang 050011,China
*
Corresponding author:ZHANG Dongxue,Nurse-in-charge;E-mail:125657481@qq.com
【Abstract】 Background The maintenance of autogenous arteriovenous fistula (AVF) is crucial to diabetics with
hemodialysis. Far infrared therapy (FIR) can significantly improve the condition of AVF in these patients. But the protective
effectiveness of FIR using HITH-4 type apparatus combined with external use of Hirudoid for AVF in diabetic patients is less
reported. Objective To explore the protective effect of FIR using HITH-4 type apparatus and external use of Hirudoid for
AVF in diabetic hemodialysis patients. Methods Sixty diabetic patients with hemodialysis were selected from 2020-01-01 to
2020-06-01 in the Department of Nephrology,the Fourth Hospital of Hebei Medical University using an AVF,and equally,
randomly divided into a control group and an intervention group. The control group received local application of Hirudoid Cream,
and the intervention group received FIR using HITH-4 type apparatus for irradiating the limb of the arteriovenous fistula side and
local application of Hirudoid Cream. The puncture point healing time,disappearance time of the puncture site scab,dialysis
blood flow,arterial pressure,brachial artery blood flow and complications of AVF were compared between the two groups after
a six-month intervention. Results Two groups had no significant differences in demographics (P>0.05). Compared with the
control group,the puncture point healing time and disappearance time of the puncture site scab in the intervention group were
significantly shorter (P<0.05). The dialysis blood flow and arterial pressure in the intervention group were significantly higher
基金项目:河北省重点研发计划项目(20377704D);河北省医学科学研究重点课题(20170174)
050011 河北省石家庄市,河北医科大学第四医院肾内科
*
通信作者:张东雪,主管护师;E-mail:125657481@qq.com
本文数字出版日期:2022-08-16